INTRODUCTION
Progression through mitosis is regulated by a number of protein kinases (1) . One of these is Aurora B, an essential kinase that is required for chromosome alignment at the metaphase plate and for completion of cytokinesis in metazoan cells (2±7; reviewed in 8). Aurora B may also be involved in mitotic chromosome condensation, but the extent of this involvement is unclear (3, 6, 9, 10) . Aurora B is a chromosomal passenger protein. Chromosomal passengers are a class of proteins that show a complex and de®ned localisation during mitosis; associating along the chromosome during prophase, concentrating at the centromere at metaphase and moving from the centromere to the central region of the mitotic spindle at anaphase (11) . Other chromosome passengers include INCENP and survivin, both of which physically interact with Aurora B. INCENP or survivin de®ciency causes Aurora B mislocalisation and cellular defects indistinguishable from those occasioned by Aurora B de®ciency, while the loss of Aurora B prevents both INCENP and survivin from behaving normally (2,4,6,12±15) . The appropriate localisation of INCENP and survivin also requires the cohesin subunit, Scc1 [(16) and C.Morrison, P.Vagnarelli and W.C.Earnshaw, unpublished data], implying that the activities of the chromosome passengers are closely linked to the other key processes occurring during mitosis.
Histone H3 is serine-phosphorylated by Aurora B (2, 3, 6, 14, 17) , as are CENP-A (18) and myosin II regulatory light chain (19) , although the effects of these modi®cations are not yet clear. The in vitro activity of the Caenorhabditis elegans Aurora B kinase, AIR-2, is enhanced by the presence of ICP-1, the C.elegans INCENP, which is a target for serine phosphorylation by the kinase (20) . The budding yeast homologue of Aurora B, Ipl-1p, which is necessary for symmetric chromosome segregation, phosphorylates the kinetochore component Ndc10p (21, 22) , and a recent model for Ipl-1p function has suggested that an unknown kinetochore Ipl-1p target may be the mediator of Ipl-1p control of the attachments between the spindle pole bodies and the kinetochores that result in bipolar kinetochore attachment (23) . Clearly, the identi®cation of further substrates of Aurora B kinase is an important issue in de®ning the mechanism by which the passengers control mitotic events.
Recent advances in the ability to identify peptides present in mixed protein samples using mass spectrometry have provided an invaluable tool for the analysis of cellular subfractions (24±26). One such fraction is the metaphase chromosome, which can be prepared from mitotically-blocked tissue culture cells (27) . The chromosome scaffold fraction comprises the residual insoluble, non-histone proteins that remain after extraction of nuclease-digested, isolated metaphase chromosomes by high salt, low ionic strength or chaotropic buffers (27) . Proteins that have been identi®ed in this fraction include CENP-E, DNA topoisomerase II and the condensin subunit, ScII (28±31) and kinetochores are also components of the scaffold (32) . Candidate Aurora B substrates might be anticipated in metaphase chromosomes, or in the chromosome scaffold fraction. Here we describe experiments in which we characterise the components of partially-extracted metaphase chromosomes using mass spectrometry in order to identify potential Aurora B substrates.
MATERIALS AND METHODS

Cloning, protein overexpression and puri®cation and antibody preparation
An EST containing a cDNA for human Aurora B was obtained from the UK HGMP Resource Centre (Babraham, UK) and subcloned into pGEX4T (Amersham Biosciences UK, Little Chalfont, UK). For site-directed mutagenesis of the pGEX4T-Aurora B construct, the QuikChange kit (Stratagene, La Jolla, CA) was used, following the manufacturer's instructions, with the primer 5¢-CAT TTC ATC GTG GCG CTC CGA GTC CTC TTC AAG TCC-3¢. Bacterial overexpression and chromatography over glutathione-sepharose was performed as previously described (2) . For polyclonal antibody generation, rabbits were immunised with gel-puri®ed GST-Aurora B: this yielded anti-Aurora B antiserum R902. Human topoisomerase II alpha (topo IIa) was expressed and puri®ed from Saccharomyces cerevisiae as described previously (33, 34) .
Total RNA was extracted from HeLa S3 cells using Trizol (Invitrogen, Carlsbad, CA) and reverse transcription using oligo(dT) primers performed using the Superscript system (Invitrogen). Ampli®cation of the CRFG sequence was performed with LA-Taq (Takara Bio, Shiga, Japan) and the product cloned into pEGFP-N1 and pEGFP-C1 (BD Clontech UK, Cowley, UK) using the XhoI and HindIII sites contained in the primers 5¢-ACT CGA GAA ATG GCA CAT TAC AAC  TTC AAG-3¢ and 5¢-AAA GCT TTC TCC TGT CCT TTT  TAC CAG C-3¢, respectively. Cell culture, transfection and microscopy HeLa JW cells were grown in RPMI 1640 medium (Invitrogen) supplemented with 10% foetal bovine serum (FBS) and antibiotics, while HeLa S3 cells were grown in the same medium supplemented with only 5% FBS and antibiotics. HeLa S3 cells were treated with colcemid (0.1 mg/ml) for 2 h before harvest and were then hyptotonically swollen in 75 mM KCl for 10 min before being dropped on to polylysine coated slides. Transfection of HeLa JW cells was performed using Fugene 6 reagent (Roche, Basel, Switzerland). For microscopy, cells were ®xed with 4% paraformaldehyde and permeabilised with 0.15% Triton in cytoskeleton buffer (137 mM NaCl, 5 mM KCl, 1.1 mM Na 2 HPO 4 , 0.4 mM KH 2 PO 4, , 2 mM MgCl 2 , 2 mM EGTA, 5 mM PIPES, 5.5 mM glucose). Monoclonal anti-a-tubulin B512 was from Sigma (St Louis, MO) and was used in immuno¯uorescence applications at 1:2000 dilution. The monoclonal AIM-1, which recognises Aurora B, was used at 1:200 dilution and was obtained from BD Transduction Laboratories (Lexington, KY). Rabbit polyclonal anti-topoisomerase II (29) was used at 1:50. Fluorescently labelled secondary antibodies were from Jackson Immunoresearch Laboratories (West Grove, PA) and were used at 1:200 dilution. Micrographs consist of single plane projections of deconvolved, three-dimensional data sets taken with a DeltaVision microscope (Applied Precision, Issaquah, WA) or of images captured with a CCD camera (Princeton Instruments, Trenton, NJ) from an Axioplan 2 microscope (Zeiss, Jena, Germany).
Chromosome preparation and immunoblotting
Chromosomes were prepared by sequential sucrose and Percoll gradients from colcemid-treated HeLa S3 cells according to Lewis and Laemmli (27) . Unless otherwise stated, chromosomes were resuspended in 5 mM Tris±Cl pH 7.4, 2 mM KCl, 375 mM spermidine (Sigma, St Louis MO), 0.01% Ammonyx Lo, 1 mM CaCl 2 plus protease inhibitors (aprotinin, PMSF and chymostatin, leupeptin, antipain and pepstatin) and digested for 1 h at 4°C with 30 mg/ml micrococcal nuclease (Sigma). For partial extraction (27, 35, 36) , chromosome suspensions were diluted 1:1 with 2Q dextran sulphate/heparin lysis buffer [20 mM Tris±Cl pH 8.8, 20 mM Na-EDTA, 0.2% Ammonyx Lo, 0.4 mg/ml dextran sulphate (Amersham), 0.04 mg/ml heparin (Sigma)], incubated for 5 min on ice and spun for 10 min at 10 000 g. More extensive extractions were performed as previously described (27, 36) . Pellets were resuspended in SDS± polyacrylamide gel electrophoresis (SDS±PAGE) sample loading buffer and chromosome protein samples were resolved on SDS±PAGE gels and transferred to nitrocellulose membranes by standard means. Membrane strips were incubated with antibodies to ScII (37) at 1:2500, human anticentromere antiserum GS (38) at 1:2500, anti-CENP-C (39) at 1:2500, anti-INCENP ra2 (40) at 1:1000 and anti-Aurora B (R902), prepared as described above, at 1:500. Antibody binding was visualised by incubation with 125 I-Protein A (Amersham). Immunblotting with the monoclonal MPM-2 (Upstate Biotechnology, Lake Placid, NY) was performed at 1:1000 dilution and signal was visualised by enhanced chemiluminesence (Amersham).
Kinase assays
Chromosomes were resuspended in kinase buffer 1 (10 mM HEPES pH 7.5, 100 mM KCl), kinase buffer 2 (10 mM HEPES pH 7.5, 20 mM KCl), kinase buffer 3 (50 mM Tris±Cl pH 7.5, 100 mM KCl) or kinase buffer 4 (50 mM Tris±Cl pH 7.5, 20 mM KCl), containing 10 mM MgCl 2 and 1 mM CaCl 2 , plus a protease inhibitor cocktail. Following Nucleic Acids Research, 2002, Vol. 30, No. 23 5319 micrococcal nuclease digestion as described above, heat treatment, if indicated, consisted of 10 min incubation at 65°C followed by at least 5 min incubation on ice. Topo IIa was heat-treated prior to its being incubated with or without Aurora B kinase in kinase buffer. Kinase assays were carried out in the presence of 1 mM ATP, 1 mM dithiothreitol, 20 mM EGTA and 2.5±5 mCi [g-32 P]ATP per 100 ml, along with fresh protease inhibitors, at 37°C for 20 min, at which point reactions were extracted as described above and prepared for SDS±PAGE.
Matrix-assisted laser desorption/ionization time-of-¯ight mass spectrometry (MALDI-TOF MS)
Protein identi®cation was accomplished by peptide mass ®ngerprinting and sequence database searching (41) . Proteins were separated by SDS±PAGE and relevant protein bands were cut from the gel by using a scalpel. In-gel digestion of protein by trypsin was performed as previously described (42), followed by sample preparation using miniaturised sample concentration/desalting techniques (43) . Two separate mass spectrometry research laboratories were involved in these experiments. However, several proteins were identi®ed in both sets of experiments, thereby con®rming both protocols. For one preparation of proteins, the mass spectrometry system was Re¯ex IV (Bruker-Daltonics, Bremen, Germany), for another we used a PerSeptive Biosystems Voyager DEÔSTR MALDI-TOF mass spectrometer (Applied Biosystems, Foster City, CA). Peptide ion signals were assigned with a mass error <50 p.p.m. Lists of tryptic peptide masses were used to search protein sequence databases using the ProFound internet-based protein identi®cation tool (44) available at http://prowl.rockefeller.edu/cgi-bin/ProFound or the MS-Fit tool (http://prospector.ucsf.edu/ucsfhtml4.0/ms®t.htm). For positive identi®cation, a MOWSE (45) score of 10 4 and at least 20% coverage of the protein by the peptide fragments was required for`small' proteins (<100 kDa), but 5±10% coverage was allowed for high molecular weight proteins (>100 kDa). Where indicated, we used an`Exp value', which is a probability based expectation value which in all cases provided a signi®cant score for a positive protein identi®cation.
RESULTS
A metaphase chromosome fraction can be prepared from colcemid-treated tissue culture cells by Dounce homogenisation and sequential density gradients (27) . The metaphase chromosome scaffold generated by stringent extraction of histones from this fraction includes the kinetochore and contains several prominent protein bands upon SDS±PAGE resolution, notably topoisomerase II and ScII (27, 29, 32, 35, 36) . A less stringent procedure was followed here, to retain more chromosome-associated material in the search for candidate Aurora B substrates. To con®rm that the resultant fraction, shown in Figure 1A and B, indeed contained the chromosome scaffold proteins, we performed immunoblot analysis with antibodies speci®c for various proteins expected to be in the scaffold. As shown in Figure 1C , this partiallyextracted scaffold contained CENP-A, CENP-B, CENP-C, INCENP, Aurora B and ScII. The monoclonal antibody MPM-2, which recognises a mitotic phosphoepitope, also detected a number of bands. To con®rm the reproducibility of this extraction protocol, 11 separate chromosome preparations were run on the same one-dimensional gel. Visual inspection of the band patterns of these different preparations revealed them to have essentially the same composition (data not shown). To examine how this extraction procedure compared with the more stringent protocols previously published, we performed gel electrophoresis on equivalent amounts of chromosomal protein extracted by differing methods. As shown in Figure 1D , there exist clear differences between the protein scaffold fractions prepared by the different extraction methods, but further analysis will be necessary to determine to what extent the content of minor, possibly unknown, components of the scaffolds is increased under the different conditions.
To de®ne the components of this chromosome subfraction, we subjected the preparations to one-dimensional SDS± PAGE (Fig. 1A and B) and excised individual bands from Coomassie-stained gels. MALDI-TOF analysis of the peptide composition of these bands was performed and proteins in the fraction identi®ed by database comparison. Table 1 lists the proteins identi®ed in this initial analysis of the extracted chromosome fraction and Figure 2 summarises these results graphically. Of the 62 proteins identi®ed in the fraction, 29% are nuclear or chromosome-associated. Some 34% are primarily associated with membranes or the cytoskeleton, 18% are mitochondrial, 3% centrosomal and the remainder are from the cytoplasm, act as chaperones or have unknown properties. Since the extent to which the cytoskeletal proteins interact with the chromosomes in forming a scaffold is not clear, some of the cytoskeletal proteins may actually represent chromosome-associated material, rather than artefactual or contaminant protein. We hypothesise that the mitochondria may be co-fractionating with the chromosomes in the Percoll density gradients, which would explain the relatively high proportion of mitochondrial proteins identi®ed.
To test whether the identi®cation of proteins by this method can de®ne new chromosomal proteins, we examined the localisation of the putative GTP-binding protein NGB/CRFG during mitosis. Green¯uorescent protein (GFP)-tagging in pEGFP-C1 and transfection of the gene encoding this protein into HeLa JW cells revealed that it forms subnuclear assemblies in interphase, as has been noted previously (46) , but that it is associated with chromosomes throughout mitosis (Fig. 3) . Transfection with pEGFP-N1-CRFG did not result in any detectable GFP signal and use of the vector alone gave rise to the typical diffuse staining of GFP throughout the cell cycle (data not shown). The perichromosomal localisation, seen clearly in metaphase (Fig. 3B) , has been observed for a number of nucleolar proteins, but does not exclude a role for this protein in mitotic chromosomes, nuclear function or in cell cycle control (47, 48) . These ®ndings con®rm that the analysis of scaffolds in this manner is a useful means to discover new proteins associated with mitotic chromosomes.
Since Aurora B itself was shown to be in the chromosome fraction, we tested whether there was a kinase activity associated with the preparation. A number of different buffer conditions were assayed and a reproducible pattern of phosphorylated bands was found to result upon incubation of the chromosomes with [g-32 P]ATP (Fig. 4A) , irrespective of the buffer used. This activity was lost upon heat treatment (Fig. 4B ). At present, the identities of the endogenous kinases that carry out this phosphorylation are unknown.
To identify new potential substrates of Aurora B, we next incubated the heat-inactivated, extracted chromosomes with recombinant human Aurora B kinase. As shown in Figure 4B , incubation of the chromosomes with the recombinant enzyme resulted in the phosphorylation of a number of proteins, notably giving rise to a strong band at the approximate size of the histones. Distinct bands were observed that indicated substrates with apparent molecular masses of approximately 16, 20, 22, 32, 39, 52, 56, 62, 76, 105 and 170 kDa (Fig. 4B) . That these were not the same as those found following the incubation of the chromosomes with radiolabel but without recombinant enzyme indicates that Aurora B is not the only kinase in the fraction and that the recombinant enzyme we prepared has a restricted speci®city for its activity. Next, to identify candidate substrates for Aurora B, we performed onedimensional SDS±PAGE and excised bands that corresponded in size to those phosphorylated in parallel experiments (Fig. 4B) . MALDI-TOF analysis of these bands identi®ed the proteins listed in Table 2 . MALDI-TOF analysis of a negative control region, which contained no distinct bands, gave a complex mixture of peptides and no protein was identi®ed. This list includes a number of potentially relevant Aurora B substrates, based on intracellular distribution. It should be noted that the most common investigator-derived, artefactual keratin contaminants are keratins 1, 2 and 10, so that the keratins 8 and 17 found here are likely real components of the HeLa preparation. Three nuclear proteinsÐthe GTP-binding protein NGB, topo IIa and CAPCÐwere identi®ed as candidate Aurora B substrates in this screen, with the DEAD/H box polypeptide 30 representing a possible fourth. It should be noted that the experiment performed to identify potential Aurora B substrates (using ProFound) was carried out at the beginning of our study, separately to the work used to generate the bulk of the data in Table 1 (using MS-Fit, generating MOWSE scores), so that the peptides identi®ed in the screen in Table 2 are clearly not the only components of the bands we examined.
Since it is known that topo IIa is a phosphoprotein (49±54), we then tested whether it could serve as an in vitro substrate for Aurora B. Recombinant topo IIa and recombinant Aurora B were co-incubated in the presence of [g-32 P]ATP and we found that Aurora B did indeed phosphorylate the topoisomerase, as well as itself (Fig. 5) . As a control for the speci®city of this phosphorylation, we incubated topo IIa with a recombinant kinase-inactive Aurora B in which a key active site residue was mutated from lysine to arginine (7) . This protein failed to phosphorylate topo IIa (Fig. 5) , con®rming that this is an activity derived only from functional Aurora B. It is noteworthy here that the Aurora B activity was very dependent on buffer choice, even though the kinase was active on chromosomes to essentially the same extent in either Trisor HEPES-containing buffers (data not shown). This may Each protein identi®ed was given only a single classi®cation. Abbreviated classi®cations were: C, centrosomal; H, chaperone; M, mitochondrial; N, nuclear/ chromosomal; S, cytoskeletal/membrane component; U, unknown; Y, cytoplasmic. Apparent masses were derived from the preparative gels from which MALDI-TOF identi®cation was performed. Degradation and/or proteolytic cleavage is assumed to account for sizes signi®cantly smaller than the published molecular weight. MOWSE scores were derived using the MS-Fit tool and`Exp values' a using the ProFound programme. re¯ect the likely presence of co-factors necessary for optimal activity of the enzyme, e.g. INCENP, in the chromosome preparation, which are not available to the reaction with recombinant protein. Attempts to localise phosphorylation sites using Fe(III)-IMAC and electrospray tandem mass spectrometry (55) revealed one endogenously phosphorylated residue in the recombinant topoisomerase II. No Aurora B phosphorylation sites in topo IIa were identi®ed, due perhaps to the low ef®ciency of the phosphorylation activity and to the large size and complexity of the topoisomerase molecule (i.e., there are approximately 200 serines and threonines in the peptide sequence). Since there is, as yet, no clear consensus site for the Aurora B kinase, it has been dif®cult to further explore this observation.
In order for the in vitro data to have any signi®cance in vivo, topoisomerase II and Aurora B must be able to interact during mitosis. Both are known to be nuclear proteins during mitosis and to examine the relationship between them we performed immuno¯uorescence localisation experiments. As shown in Figure 6 , topo IIa is located along the axis of the chromosomes, while Aurora B is centromeric, as expected. These ®ndings show that at least a subfraction of the topo IIa population is available for phosphorylation by Aurora B and, given recent evidence for the mobility of the topoisomerase (56, 57) , suggests that Aurora B may be able to phosphorylate a signi®cant amount of this substrate during mitosis.
DISCUSSION
Here we present the ®rst mass spectrometry-driven proteome analysis of metaphase chromosomes prepared from HeLa S3 cells. The preparative method used has been previously used successfully in the identi®cation of CENP-E, DNA topoisomerase II and condensin (28±31), all of which are found in the preparation we describe here. Despite the levels of cytoskeletal and mitochondrial material, the useful percentage of chromosome-associated material found in this preparation makes it an attractive source for further analysis. It is important to note that the relative amount of any given protein in the preparation cannot be assessed by the techniques we used here, as the various peptides from tryptic digests may behave differently during mass spectrometryÐindeed, the relatively low scores obtained for the known scaffold component, topoisomerase II, emphasise this point. We attribute the absence of many of the proteins known to be in the scaffold (e.g. the CENP proteins) from the MALDI-TOF pro®le to their relatively low abundance and to the possibility of their being poor subjects for mass spectrometric analysis. Our observations suggest that the further use of mass spectrometry against a more stringently-extracted scaffold fraction might reveal novel components of the chromosome scaffold that have not been identi®ed by antibodies.
The further characterisation of the unknown and/or poorlycharacterised proteins identi®ed in the current screen will require their localisation. This was done for the putative GTPbinding protein NGB/CRFG by¯uorescently tagging it and overexpressing it in tissue culture cells. The perichromosomal localisation, seen clearly in metaphase, does not clearly de®ne the likely role of this protein (58±62). It may re¯ect a nucleolar function for the protein (47), as might be expected from its apparent localisation in interphase (46) . However, it may also indicate some role in cell cycle controlÐa similar mitotic localisation has also been observed for the BCR oncogene product (47, 48) , which interacts with and activates GTP-binding proteins. The chromosomal localisation of NGB/ CRFG we describe here may, therefore, be in some way related to its putative role in renal disease (46) , but very little is known about this protein to date.
In the search for new Aurora B substrates, the most likely candidates are those known to have an association with chromosomes or the spindle, such as CAP-C/SMC-4 and topo IIa. Investigation of the Xenopus condensin complex showed no mitotic phosphorylation of CAP-C (63). Therefore, topo IIa, which has been well described as a phosphoprotein (49±54), was tested as an Aurora B substrate. Recombinant Aurora B indeed phosphorylated recombinant topo IIa in vitro. The functions of DNA topo IIa during mitosis have long been of interest and its phosphorylation, which varies throughout the cell cycle and is regulated by a number of kinases, appears to be of great importance in modulating its activities (64, 65) . While the localisation of topo IIa during mitosis is somewhat controversial (53,56,66±68) , its locations are consistent with its being a potential Aurora B substrate. The localisation of topo IIa at the centromere (69) further enhances the likelihood of the Aurora B interaction being signi®cant, but our inability to specify the target residue(s) by mass spectrometry has Note that additional data are provided for each of these identi®cations in Table 1 ; the ProFound analysis refers to these proteins. hampered our efforts to de®ne this signi®cance. To date, no consensus Aurora B phosphorylation signal has been described, so we cannot speculate on the potential target residues on topo IIa. While there remain further candidate substrates to be identi®ed, the complexity of the metaphase chromosome fraction may necessitate the use of two-dimensional electrophoresis to resolve phosphorylated proteins suf®ciently for their conclusive identi®cation.
In conclusion, we present the proteomic analysis of partially-extracted metaphase chromosomes as a means by which novel mitotic chromosome components may be described and by which chromosomal kinase substrates may be identi®ed. The ability to remove kinase activity endogenous to the preparation by heat treatment means that any kinase may be tested on chromosomes and the more abundant of its potential substrates described.
